Renalytix plc Capitalized Software Development Costs for Software Sold to Customers
Renalytix plc (RENXF) had Capitalized Software Development Costs for Software Sold to Customers of $1.10 million as of 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Notes
us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers · last filed 2023-09-28
- 2023-06-30: Capitalized Software Development Costs for Software Sold to Customers $1.10M.
- 2023-03-31: Capitalized Software Development Costs for Software Sold to Customers $1.10M.
- 2022-12-31: Capitalized Software Development Costs for Software Sold to Customers $1.10M.
- 2022-09-30: Capitalized Software Development Costs for Software Sold to Customers $1.10M.
| Period end | Capitalized Software Development Costs for Software Sold to Customers |
|---|---|
| 2023-06-30 | $1.10M 10-K · filed 2023-09-28 |
| 2023-03-31 | $1.10M 6-K · filed 2023-06-09 |
| 2022-12-31 | $1.10M 6-K · filed 2023-03-30 |
| 2022-09-30 | $1.10M 6-K · filed 2022-11-30 |
| 2022-06-30 | $1.20M 10-K · filed 2023-09-28 |
| 2022-03-31 | $1.10M 6-K · filed 2022-06-30 |
| 2021-12-31 | $1.20M 6-K/A · filed 2022-04-29 |
| 2021-06-30 | $1.30M 20-F · filed 2022-10-31 |
| 2020-06-30 | $600.00K 20-F/A · filed 2022-08-01 |
| 2019-06-30 | $0.00 20-F/A · filed 2022-08-01 |